Please Wait
Applying Filters...
menu
    • menu
    Quotient Sciences-PSE
    News
    Lindus & Quotient Accelerate Drug Dev from FIH to Pivotal Trials

    11 Dec 2025

    // PRESS RELEASE

    Quotient and Intrepid Labs Accelerate AI-Guided Drug Discovery

    05 Dec 2025

    // PRESS RELEASE

    Flagship Signs ProFound, Quotient Deals in GSK Pact

    20 Nov 2025

    // PR NEWSWIRE

    Data Compilation
    #PharmaFlow

    Quotient rm 250x250

    Contact Supplier

    Website

    BIO Partnering at JPM

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/RPKM51cDDyM
    Left Arrow
    Right Arrow

    Quotient Sciences- Molecule to Cure. Fast.

    Related CompaniesRelated Companies

    About

    With over 30 years of experience in drug development and manufacturing, Quotient Sciences serves as a drug development and manufacturing accelerator. It offers a range of integrated programs and tailored services to more than 550 customers and helps them optimize formulations, refine manufacturing processes, and plan clinical studies. Based on its experience with over 1,500 molecules at all stages of development, Quotient Sciences employs an innovative approach to formulation development that integrates drug product development with clinical evaluation. It operates seven manufacturing and clinical facilities in the UK and the US.
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.